Literature DB >> 11851372

The dual role of CD4 T helper cells in the infection dynamics of HIV and their importance for vaccination.

H Korthals Altes1, D Wodarz, V A A Jansen.   

Abstract

Given the role of the CD4 T helper cells in the development of memory CTL precursors, it seems beneficial to boost the CD4 T helper response in the context of vaccination against the human immunodeficiency virus (HIV). However, CD4 T cells are also the preferred targets of infection by HIV. Here, we address the question as to whether it is advantageous to stimulate the CD4 T helper cell response, as this will increase the pool of potential target cells of infection. To do so we formulated a mathematical model describing the interactions between virus-infected cells, susceptible cells, HIV-specific CD4 helper T cells, and CTL precursor (CTLp) and effector cells (CTLe). The effect of increased initial CD4 helper and CTLp numbers on the outcome of infection, as well as the effect on viral set point of increased CD4 T helper growth rate, CTL responsiveness and the rate at which CTLp and CTLe are produced were studied. We found that only when the virus has a low basic reproductive number does the number of CTLp and CD4 T helper cells at the moment of infection influence the outcome of infection. In this situation, high initial T helper and CTL numbers can switch the outcome from full-blown infection to virus control. However, this holds for virus with infectivity in a limited range, and current estimates of virus infectivity suggest that it is higher. In that case, only a vaccination protocol that increases CTL responsiveness, ideally in combination with the rate of production of CD4 T helper cells, may offer a solution as it can reduce the viral set point considerably. If brought under a certain level, the viral population might be unable to replicate any further. However, changing these parameters of the immune response is only beneficial when infection is controlled by CTL in the long term. When a CD4 lymphoproliferative response is mounted but the CTL response is not maintained, increasing the CD4 T helper growth rate is deleterious. Copyright 2002 Elsevier Science Ltd.

Entities:  

Mesh:

Year:  2002        PMID: 11851372     DOI: 10.1006/jtbi.2001.2483

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  7 in total

1.  T cell state transition produces an emergent change detector.

Authors:  Peter S Kim; Peter P Lee
Journal:  J Theor Biol       Date:  2011-01-27       Impact factor: 2.691

2.  Post-treatment control of HIV infection.

Authors:  Jessica M Conway; Alan S Perelson
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-13       Impact factor: 11.205

3.  Enhanced SIV replication and accelerated progression to AIDS in macaques primed to mount a CD4 T cell response to the SIV envelope protein.

Authors:  Silvija I Staprans; Ashley P Barry; Guido Silvestri; Jeffrey T Safrit; Natalia Kozyr; Beth Sumpter; Hanh Nguyen; Harold McClure; David Montefiori; Jeffrey I Cohen; Mark B Feinberg
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-23       Impact factor: 11.205

4.  The race between initial T-helper expansion and virus growth upon HIV infection influences polyclonality of the response and viral set-point.

Authors:  H Korthals Altes; R M Ribeiro; R J de Boer
Journal:  Proc Biol Sci       Date:  2003-07-07       Impact factor: 5.349

5.  Effectiveness of a 'hunter' virus in controlling human immunodeficiency virus type 1 infection.

Authors:  Gisela García-Ramos; Derik Castillo; Philip H Crowley
Journal:  J Gen Virol       Date:  2010-06-23       Impact factor: 3.891

6.  A strong case for viral genetic factors in HIV virulence.

Authors:  Viktor Müller; Christophe Fraser; Joshua T Herbeck
Journal:  Viruses       Date:  2011-03-08       Impact factor: 5.818

7.  Apoptosis in virus infection dynamics models.

Authors:  Ruili Fan; Yueping Dong; Gang Huang; Yasuhiro Takeuchi
Journal:  J Biol Dyn       Date:  2014       Impact factor: 2.179

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.